Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Preliminary Validation of a MALDI-TOF MS Assay Using KTI as an Internal Standard for Serum M-Protein Light Chain Analysis in Multiple Myeloma: A Pilot Study.

Medicina (Kaunas, Lithuania)·2026
Same author

[Differences in the mechanisms, diagnostic biomarkers, and therapeutic strategies of drug-induced liver injury caused by traditional Chinese and Western medicines].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2026
Same author

A computational analysis of multi-target mechanisms linking bisphenol A to precocious puberty.

PeerJ·2026
Same author

A Practical Nomogram for Preoperative Prediction of Lateral Lymph Node Metastasis in Children and Adolescent Patients With Papillary Thyroid Carcinoma: A Multicenter Retrospective Study.

Ultrasound in medicine & biology·2026
Same author

GATA2 Mutations Predict Poor Prognosis in Transplanted Myeloid Neoplasms.

Cancer medicine·2026
Same author

A Rare Blue-Light-Excitable-Near-Infrared-Emissive Copper(I) Iodide Hybrid with Facile Synthesis for Near-Infrared Imaging.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.1K

N-Acetylornithine Depletion in Bone Marrow Biopsy: A Novel Microenvironment-Specific Hallmark for Multiple Myeloma

Bingjie Wang1, Shuanglian Xie1, Weiwei Xie1

  • 1Department of Hematology, Peking University First Hospital, Beijing, China.

International Journal of Laboratory Hematology
|April 18, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for analyzing bone marrow biopsy metabolomics. Reduced N-acetylornithine levels in bone marrow biopsy tissue are associated with multiple myeloma (MM) and monoclonal gammaglobulinemia of undetermined significance (MGUS).

Keywords:
N‐Acetylornithinebone marrow microenvironmentmetabolomicsmultiple myeloma

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.1K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.1K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.1K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Area of Science:

  • Biochemistry
  • Oncology
  • Biomarker Discovery

Background:

  • The bone marrow microenvironment is critical in multiple myeloma (MM) pathogenesis.
  • Existing metabolomics research often focuses on plasma or suspension, with limited analysis of bone marrow biopsy tissue.
  • This study addresses the gap by developing a novel approach for bone marrow biopsy tissue metabolomics.

Purpose of the Study:

  • To establish a new metabolomics approach for analyzing bone marrow biopsy tissues.
  • To explore the diagnostic value of metabolomic alterations in distinguishing multiple myeloma (MM) and monoclonal gammaglobulinemia of undetermined significance (MGUS) from controls.
  • To identify potential diagnostic biomarkers for MM and MGUS.

Main Methods:

  • Bone marrow biopsy tissues were collected from newly-diagnosed multiple myeloma (MM) patients, MGUS patients, and lymphoma patients (controls).
  • High-performance liquid chromatography-mass spectrometry (HPLC-MS) was employed for metabolomics analysis.
  • Diagnostic biomarkers and associated metabolic pathways were analyzed.

Main Results:

  • Distinct metabolic profiles were observed between control, MGUS, and MM groups.
  • N-acetylornithine was significantly down-regulated in MM compared to both controls and MGUS, showing high diagnostic value (AUC 0.933 for MM vs. controls).
  • Arginine biosynthesis pathway, involving N-acetylornithine, was identified as disrupted in MM compared to MGUS.

Conclusions:

  • A novel method for metabolomic profiling of bone marrow biopsy tissue was successfully established.
  • Metabolic alterations, specifically reduced N-acetylornithine levels, were identified in patients with MGUS and MM.
  • This metabolomic approach holds promise for the diagnosis of plasma cell disorders.